As we await the FDA’s upcoming decision regarding Pfizer’s coronavirus vaccine candidate, experts are concerned that second shot no-shows could impact vaccination efforts. And open the door for the virus to mutate.
Tag
As we await the FDA’s upcoming decision regarding Pfizer’s coronavirus vaccine candidate, experts are concerned that second shot no-shows could impact vaccination efforts. And open the door for the virus to mutate.